Immunity :: Immune police recognize good and bad guys in the body
Immune system police are as good at recognizing bad guys, such as bacteria and viruses, as they are our own tissue, researchers say.
Health Insurance :: Internal medicine physicians recommend key elements to guide state initiatives
A white paper that examines various state initiatives to expand access to health insurance, as well as proposals by the President and Congress in support of state efforts, was distributed today by the American College of Physicians.
Lazy Eye :: No need for children with lazy eye to wear patches all day
Children with amblyopia (commonly known as lazy eye) need only wear an eye patch for three to four hours a day for 12 weeks to improve vision, say researchers in a study published on bmj.com today.
Bird Flu :: Crucell to present pre-clinical results for H5N1 Virus treatment
Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL, Swiss Exchange: CRX) announced that its researchers have discovered a monoclonal antibody that is active against H5N1 avian influenza. The studies will be presented at the 5th International Bird Flu Summit scheduled for September 27 and 28 in Las Vegas, Nevada.
Breast Cancer :: FDA approves Evista to reduce breast cancer risk in postmenopausal women
The U.S. Food and Drug Administration approved Evista (raloxifene hydrochloride) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
Blood Pressure :: Genes and drugs team up to lower blood pressure
Patients with high blood pressure respond very differently to anti-hypertensive medication, making treatment selection tricky for physicians. But new research published in the online open access journal, BMC Medical Genetics, pinpoints a number of gene-drug interactions that could allow medication to be tailored to individual patients based on their genetics.
Cancer Pain :: Cephalon reinforces Fentora”s prescribing & dosing information
Cephalon, Inc. (Nasdaq: CEPH) communicated with healthcare professionals to clarify the appropriate patient selection, dosing and administration for FENTORA(R) (fentanyl buccal tablet) [C-II].
Microchip :: VeriChip believes no link between microchip and malignant tumors in humans
VeriChip Corporation (NASDAQ: CHIP), a provider of RFID systems for healthcare and patient-related needs, responded in an effort to set the record straight in response to unbalanced press reports relating malignant tumors to the Company’s implantable microchips.
Eating :: Mums feel they get a serve over preschoolers” eating habits
Fear of being criticised by others may be leading Australian mums to be overly concerned about preschoolers being underweight, a new study has found.
Heart :: FDA recommends Bayer”s Trasylol for continued sale in US
The Cardiovascular and Renal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to the U.S. Food and Drug Administration (FDA) held a meeting to discuss the risk /benefit profile of Trasylol(R) (aprotinin injection), a Bayer drug used in coronary artery bypass graft (CABG) surgery.